# Labetalol Hydrochloride

NDC: 0143-9623
Generic name: Labetalol Hydrochloride
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 19991129

FDA application: ANDA075303

## Active ingredients

- LABETALOL HYDROCHLORIDE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9623"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9623
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30f9fdef-8781-4327-9a8d-812cb31ff041